Outsourcing in Clinical Trials Nordics (OCT)

Direct-to-Patient shipment: Time to Stop and Think


Eric Schnitzer presents how Direct-to-Patient shipments were managed during COVID, the benefits and limitations of current solutions, and what the future of DtP should look like.

2021 年 10 月 26 日


Eric Schnitzer image

Eric Schnitzer

Product Director, Calyx

Eric is a Product Director at Calyx with over 15 years of experience in eClinical technologies for clinical trials as well as for other healthcare products. He has a background working with various IRT solutions and with clinical supply groups from many Pharmaceutical and Biotech companies.



  • 此字段用于验证目的,应保持不变。
Powered by Translations.com GlobalLink OneLink Software